Background: There is a controversy about the usefulness of FNA cytology in the diagnosis of lymphoma. However, cytological samples have been used as highly accurate for diagnosing lymphoma. State of art diagnostic techniques is available for cytological samples, including a wide range of immunocytochemical markers, molecular tests, and flow cytometry. The aim of this study is to evaluate the utility of cytological samples for the diagnosis of lymphoma. Methods: 102 FNA cytological samples diagnosed as lymphoma were reviewed. 60 cases had smears only and 40 cases had both smears and cell blocks. Samples were obtained through: EUS, EBUS, direct FNA and cytological imprints from surgically resected lesions. ROSE was performed in all FNA procedures. In most cases, one of the passes was sent to flow cytometry analysis at the time of FNA procedure. Molecular analysis (PCR and/or FISH) was performed in most cases of non-Hodgkin lymphoma. When surgical specimen was available, cytology and histology were compared. In those cases without histology, cytological diagnosis was compared to clinical follow-up. Results: 15 classical hodgkin lymphomas and 77 non-hodgkin B-cell lymphomas were evaluated. In all available cases: (i) FNA cytology and flow cytometry were concordant; (ii) full agreement between cytology and histology was achieved. Molecular analysis was a useful adjunct to cytologic examinationin 80 cases. Patients were treated based on the final cytological report. Clinical follow-up was in agreement with what was expected depending on the different types of lymphoma diagnosed. Conclusions: FNA cytological samples are a safe and reliable method for diagnosing lymphoma. Either smears or cellblocks are useful. A comprehensive cytological diagnosis should include flow cytometry analysis using material obtained "in situ" at the time of FNA procedure. PCR and FIHS analysis refined the cytological diagnosis when needed. Rose is strongly recommended. A careful management of the samples is mandatory. Objectives: Fine-Needle Aspiration (FNA) is increasingly being used as a first diagnostic tool to evaluate sarcomas. Molecular tests have increased the efficacy and diagnostic accuracy of FNA. Here, we present a series of 73 cases of sarcomas diagnosed by FNA. Methods: We reviewed 73 sarcomas diagnosed by FNA from 2008-2018. In 30 superficial lesions, FNAs were performed by a cytopathologist. In 43 lesions, FNAs were taken under CT and/or EUS imaging guidance. In all procedures, ROSE was applied. In all cases, tissue biopsy and/or surgical specimens were available. Cytology/histology correlation was evaluated. In 56 cases, molecular testswere performed.
whether these women had cervico vaginal involvement by HPV prior or after AC.
Results: 644 cases of AC, only 114 in women (17.7%). Mean age was 52.02 years. Cytological diagnosis was negative in 73.7%, ASC-US in 9.6%, L-SIL in 10.5% and H-SIL in 0.9%. Five samples were inadequate for diagnosis. PCR HPV identification was undertaken in 53 patients and the most frequent diagnosis was multiple high risk virus (50.9%). In 15 patients no virus was detected. Infection rate by HPV16 and 18 was low (5 patients). Anal biopsy was performed in 35 cases. Most cases were condilomas (12 cases), but we found 5 squamous cell carcinomas and 4 HSIL. Only one of those 9 cases had a cytological diagnosis of HSIL. The diagnostic accuracy of anal cytology was low with a sensitivity of 33.3% and a negative predictive value 76.5%. 66% of the patients had no prior diagnosis of cervicovaginal HPV infection, but in 55.2% (63 patients) synchronous cervicovaginal cytology was performed, revealing 9 LSIL, 6 HSIL and 11 ASCUS. VPH in all these cases revealed the serotypes were similar to those found in the anal sample, although 3 cases with multiple high risk virus in anal simple did not show virus in cervicovaginal ones.
Conclusion: AC is less widely used in women than in homosexual men; sensitivity of the technique is low and our results indicate cervicovaginal infection is not always present in cases with anal disease. Methods: Cytologic smears, stained with Papanicolaou and May Grunwald Giemsa and corresponding histopathologic (n = 7) and immunostained sections (n = 6) were reviewed by BR with SK.
Immunohistochemical staining was performed on corresponding tissue sections by polymer detection technique on 3 lm thick sections mounted on tissue bound coated slides.
Results: Eight tumors occurred in 6 males and 2 females with age ranging from 36-72 years (average = 55), in the sacrum (6) and in the spine (2) . Initially on fine needle aspiration cytology (FNAC), 5 cases were either diagnosed or "suggested" as chordomas, and two were diagnosed with chordoma as a differential diagnosis. On review, smears were moderately cellular with myxoid stroma (8/8); epithelioid cells (8/8); discernible nucleoli (6/8) and physaliphorous cells (5/8). Variable features were binucleation (1/8), pleomorphic cells (1/8) and intranuclear inclusions (1/8) . Immunohistochemically, tumor cells expressed cytokeratins (5/5), EMA (6/6), S100protein (5/ 7) and brachyury (7/7). Four patients underwent surgical excision, including one with adjuvant radiotherapy (RT) and 4 underwent RT.
During follow-up (n = 7) (duration = 4-53 months), a single patient developed recurrence; 3 had persistent disease and another patient presented with multiple/metastatic lesions. Finally, 5 patients were alive with disease (7-53 months); a single patient was free of disease (4 months) and a single patient died-of-disease.
Conclusion: Chordomas can be primarily diagnosed by FNAC in a typical clinico-radiologic setting with combination of cytomorphologic features, including myxoid stroma; epithelioid/polygonal and physaliphorous cells. An exact diagnosis has treatment implications and requires confirmation by immunostaining, especially brachyury, which is the most specific marker for differentiating this tumor from its diagnostic mimics, including parachordomas, chondrosarcomas and metastatic adenocarcinomas. This study constitutes as the first series on cytopathology of chordomas, confirmed by brachyury immunostaining, from our country.
O6 MOLECULAR AND IMMUNOCYTOCHEMISTRY
O6-1 | Cytology Smears as a Diagnostic Method of Colorectal Carcinoma Lymph Nodes. Correlation with Molecular Analysis M. Cuatrecasas 1, 2, 3, 4 Objectives: Colorectal carcinoma (CRC) guidelines base pN staging on the gold standard H&E lymph node (LN) analysis, which confers low sensitivity in early-stage CRC for a reliable pN0 stage. Furthermore, the presence of occult tumor cells within LNs is an important prognostic factor and can be overlooked on conventional histopathology examination. The molecular method of LN analysis could be an alternative to H&E, especially in early CRC. We aimed to use the entire LN for molecular assay and simultaneously give the standard pN stage with a morphological-cytology base.
Methods: Analysis of 1001 LNs from 54 CRC patients was performed from December 2016 to July 2017. LNs were dissected on the long axis, half was used for cytology smear + CK19 immunocytochemistry, H&E and CK19 immunohistochemistry (IHC), and the other half was processed for the RT-LAMP molecular assay. The pN obtained with the three morphology-based methods of LNs analysis were compared among them and with the values of the molecular results.
Results: The number of positive LNs per patient and the number of patients with positive LNs was higher with cytology smears+CK19 immunostains (18 patients) than with H&E alone (15 patients). Cytology smears detected 5.6% more patients than H&E (p < 0.0001). Additional CK19 IHC on FFPE LNs increased tumor detection in 1.9% (16 patients). Molecular method of LN analysis detected higher number of patients with presence of tumor burden in LNs than any other morphology-based method (20 patients; p < 0.0001).
Conclusions: Cytology smears + CK19 immunostainsenables to use the pN stage according to current guidelines, and allows to use the entire LN tissue for molecular determination, a more sensitivemethodof LN tumor detection in CRC. This approach could replace H&E and obtain a more accurate pN staging CRC patients. Results : The positive rate of ALK (D5F3) fusion protein expression in advanced lung adenocarcinoma was 11.56% (17/147) while in direct smears and ThinPrep cytology slides reached 10.64% (5/47) and 12.00% (12/100), respectively, which showed a completely conformity between the two methods (p = 1.000,>0.05.) All 17 positive cases referred to RT-PCR analysis on cytology specimens. Only one positive case based on ThinPrep cytology slide showed negative in PCR. Among 40 negative cases who have corresponding FISH or IHC testing results on formalin-fixed tissue, 39 of cases demonstrated coincident results with ICC, apart from one case showed ICC negative but IHC strong staining with prominent tumor heterogeneity. Therefore, the sensitivity and specificity in direct smears both reached 100% while 91.67% and 96.67% respectively in ThinPrep cytology slides.
Conclusions: Direct smears and ThinPrep cytology slides in FNA
samples can be used in the detection of ALK(D5F3) ICC analysis of advanced lung adenocarcinoma, especially for those who have difficulty in making cellblock to perform gene analysis. Objectives: At Hospital Universitario La Paz, we are introducing molecular biology techniques in our daily routine to provide the most definitive diagnosis that is feasible using cytology specimens.
O6-3 | Molecular Biology in Cytology
We review molecular biology tests performed during 2016-2017 excluding lung and breast cancer specimens, because they are subject to a specific in-house protocol to decide whether to use cytology or biopsy samples for these techniques. Results: 121 cases (93%) were successfully analyzed using the NGS panel. 3 smears (3.4%) and 6 cell blocks (14.3%) did not pass through quality control metrics. 8 out of the 9 cases failed at NGS obtained at least the evaluation of EGFR and ALK status with RT-PCR platform and IHC or FISH. The mean DNA concentration valued with Qubit® fluorometer was 1.94 ng/ml in cell blocks and 5.4 ng/ml in smears (p < 0.05).Molecular aberrations were found in 75% of cell blocks and in 84.7% of smears (p = 0.09).
Conclusions:
The study highlights the feasibility of targeted nextgeneration sequencing on cytological samples in clinical setting. The majority of tumors harbored mutations in clinically-relevant genes. Objectives: Identifying EGFR and KRAS mutations is crucial to offer a targeted therapy in advanced cases of non-small cell lung carcinoma (NSCLC). Peripheral pulmonary lesions are still a challenge in clinical practice due to the difficulty of approaching by standard bronchoscopy and the need to obtain large samples for pathological and molecular diagnosis.
The aim of this study was to establish the viability of detecting EGFR and KRAS mutations using brush cytology in RPMI culture media obtained by radial-probe EBUS (R-EBUS) in patients with a suspicious of NSCLC to deal with the difficulty to test on small samplings or difficult cases to obtain biopsy specimens.
Methods: A bronchial brush for cytological routine evaluation and for a mutational analysis of EGFR and KRAS genes was performed in 36 patients suspicious to have a peripheral lung carcinoma, from June 2015-November 2017. Samples were received as cytological smears to diagnostic purposes and in RPMI medium to molecular analysis by real-time PCR using the TheraScreen EGFR RGQ PCR kit (Qiagen), and Sanger sequencing (EGFR, KRAS). The molecular profiling was repeated in those cases which also had a previous histological sample.
Results: Among the 36 cases, 23 were positive for NSCLC and the other 13 were negative for malignant cells. From the 23 positive cases, mutations were detected in 13 (10 KRAS and 3 EGFR). The histological sample was obtained in 12/23 cases and the subsequent tissue molecular detection confirmed the cytological result in all the available cases (5 KRAS, 2 EGFR and 5 Wild type). The cyto-histological correlation was 100%.
Conclusions: Molecular profiling performed on bronchial brushing obtained by cytological smears in RPMI medium could be a standard procedure to be incorporated in the routine diagnostic of peripheral NSCLC. It provides adequate material for molecular studies to guide faster clinical and therapeutic decisions. was found in 1, 2, 2 and 9 cases out of 14 positive cases. One case showed Dot stain and most >50% PD-L1 expression had also cytoplasm stain. Rate of invalid studies was 18.92% due to absence of correct internal control and background stain (necrosis). Invalid rate of archived cases were similar (20% vs. 23.1%) (v 2 = 0.581). Percentage of tumor cells in paired cytoblocks was concordant. MGG and PAP smears prepared. Cytomorphology was studied. Cell Block was prepared wherever feasible and immunohistochemistry markers studied Correlation with the clinical and radiological findings was done to arrive final diagnosis. All the cases were followed up and histopathology correlation was made in those cases that underwent biopsy/surgery.
O9-3 | Feasibility of Cytological Samples for PD-L1 Assessment in Lung Cancer

Conclusions:
Results:
Age ranged from 20 months to 75 years with slight male preponderance. Out of twenty eight cases, Thymoma accounted for the majority of the cases (n = 19; 67.8%), thymic carcinoma were 6, (21.4%), one case of thymic hyperplasia (0.04%), thymolipoma (0.04%) each and thymic neoplasia-not categorized one (0.04%).
Four cases of thymoma were associated with myasthenia gravis Thymoma showed expression of CK, CD3, CD5, CD20, along with TdT, CD1a and CD99. Thymoma B3 expressed CK and focally EMA. Thymic Carcinomas expressed CK, CK 7, CD5 and CD117.
CEA was seen in one case of adenocarcinoma of thymus. On follow up eight patiens were doing well, eight patients died and ten patients lost for follow up.
Conclusion: Guided FNAC can be an accurate method of diagnosing thymic lesions when correlated with clinical and radiologic findings. Additional Cell Block and Immunohistochemistry study greatly helps in definitive diagnosis. Results: PTEN expression was the lowest in the triple-negative subtype. Luminal subtypes were characterized by the highest cytoplasmic PTEN expression (p = 0.037). HER-2 positive subtype was observed to present a higher nuclear expression than in other subtypes, however the difference was not statistically significant (p = 0.073). PTEN, both cytoplasmic and nuclear, expression was significantly lower in lymph node metastases than in primary tumor site (p < 0.001). The largest alterations were observed in the luminal B subtype patients (p = 0.006 in cytoplasmic and p = 0.017 in nuclear distribution), whereas no alterations were noted in HER-2 positive subtype patients.
PTEN cytoplasmic and nuclear expression in breast cancer patients
was positively correlated with ER expression status (p = 0.046 and p = 0.006 respectively), additionally a positive correlation of PTEN nuclear expression with HER-2 overexpression was also noted (p = 0.006).
Conclusions: PTEN cytoplasmic and nuclear expression levels were
proved lower in lymph node metastases than in primary sites in breast cancer. According to our study PTEN immunophenotyping in advanced breast cancer could be important for better breast cancer characterization and further patients treatment stratification. Results: 30 false negative cases were found. Patient ages ranged 32 to 52. Cases included invasive ductal carcinoma (60%), invasive lobular carcinoma (20%), ductal carcinoma in-situ (13%), invasive mammary carcinoma and metastatic adenocarcinoma (3% each). The majority of cytologic diagnoses were benign breast tissue or fibroadipose tissue (73%), followed by fat necrosis (7%), fibroadenoma, fibrocystic changes, lactational change, gynecomastia and hematoma (each 3%). 40% of cases were limited by scant cellularity or poor preservation. Half of these cases were clinician-performed without rapid evaluation. In cases with a rapid evaluation, atypia or malignancy was suggested in 18%.Most lesions were <2 cm, and several notes reported no discernible mass among dense breast tissue. Only 10% of cases were reported as BIRADS 1 or 2.
Conclusions: Several factors contribute to false negative breast cytology. The most likely reason discovered in this study was that the FNA missed the lesion. Small lesions in dense breasts create a technical challenge. Rarely, interpretation errors led to a false negative result in this cohort. This study emphasizes the need forcaution when discordances arisein the triple test. Imaging abnormalities should also be correlated with cytologic findings. If it is suspected the lesion was missed, an explanatory note in the report is suggested. The Bethesda System (TBS) 2001 (1) provides a category to signal the presence of endometrial cells in women over 40 years, because menopausal status is often unclear. The TBS 2014 (2) Methods: This systematic review evaluates neural networks and deep machine learning applications in the field of cervical cytology.
O1 GYNECOLOGICAL CYTOLOGY
O1-1 | Diagnostic Audit of Cervical Specimens From Women Diagnosed With Invasive
PubMed was searched from 2013-2018 for relevant eligible prospective and retrospective studies of cervical slide screening specimens.
Studies were accepted with clinical endpoints or modeling.
Results: There are two basic approaches for fully automating cytology. One is for humans to identify features and then train a computer to recognize those features and classify the results categorically. The second is for a large data set to be fed to a deep learning machine with a neural network and allow the computer to self-train, without the humans predetermining the features. The out- Objectives: Malignant pleural mesothelioma (MPM) is a rare tumour but with increasing incidence and a poor prognosis. In (2015) Methods: Turkey is one of the relatively high-risk countries for MPM. Turkish Mesothelioma Working Group (WG) was founded in cians/academicians from 42 university/state hospitals in Turkey. WG members record their patients by demographic data (name, address, birthplace, diagnosis/death dates),and by clinical, imaging, and morphological findings. There are currently 6 member pathologists in the WG (including the authors with affiliation numbers of 1, 2, 3, 4) .
Results: The authors present the features of cytology (except for desmoplastic), histology, immunocytochemistry and imaging of rare types such as WDPM (4), adenomatoid tumor (5) and deciduoid (4), pleomorphic (2), signet-ring-cell (1), and desmoplastic (1) new markers such as CD20, Her2, EGFR and CD117 are being used for targeted therapy. It has led to a dramatic increase in diagnostic accuracy and also allowed the identification of markers both for prognosis and targeted therapies. In our laboratory ICH has been used in over 3000 cases as an adjunct to cytology for the last 3 years. This review will to a large extent be based on our experience from this work, but important results contributed by others will also be included. 
Keywords:
Conclusions:
In conclusion, the cytopathological evaluation of CTC according to our method is a very promising practice, which may possibly be associated with molecular biology techniques normally used in liquid biopsy, in order to make the latter more extensive evaluation, which will have major and accurate impacts on the cancer patient's management. Objectives: HPV infection is extremely common in young women.
O1 GYNECOLOGICAL
This rate has been associated with sexual behavior and biologic vulnerability, and most lesions are supposed to regress spontaneously.
Screening is usually stopped at ages 60-70 in women with previous negative tests. Our aim is to evaluate the distribution of cervical lesions in young and elderly patients.
Methods: Review of all cervical smears diagnosed in a public institution (2010-2017) and a private institution (2016) (2017) Results: We found that 35 cytologies (0.017%) showed urothelial cells. 18 were sent as blind vaginal swab (51.43%), while the other 17 cases were not specified. 10 were sent by the same gynecologist (28.57%). The average age of the patients was 68.15 years (range 36-88), and all but one were older than 48.
There are three type of urothelial cells in the smears: Intermediate and basal cells that resemble endocervical, metaplastic, or even
High-Grade Squamous Intraepithelial cells and superficial cells (umbrella cells) that look like Low-Grade Squamous Intraepithelial cells.
These cells are generally binucleated like koilocytes, but their characteristical microvacuolated cytoplasm is the clue for a correct differential diagnosis.
Conclusions:
The presence of urothelial cells in PAP smears is a very infrequent event. It´s been rarely described in advanced bladder prolapse or vesicovaginal fistulas, but nobody has proposed the possibility of a direct smear of the urethra. Most of the women in the present study are old women, with a blind vaginal swab made probably with a cotton swab and without speculum. Wherever these cells come from, the important fact is that cytotechnologists and pathologists recognize them, and do not confuse them with other pathologies, especially SIL. Inadequate cervical cytological analysis can be helped forward by glacial acetic acid (GAA) employment of primary liquid-based collections to remove mucus, erythrocytes, inflammatory cells and cellular debris.
O1-6 | The Value of Glacial Acetic Acid Treatment in Thinprep ® Specimens
We demonstrate that GAA treatment significantly increased potential to support the diagnostic process for indeterminate results.
In our study, 40 ThinPrep® specimens were collected by one laboratory. These specimens were initially defined as unsatisfactory on the basis of the Similar management for similar risk-discrimination is benchmarked.
The discrimination of risk is clinically important for cytology results of NILM, ASC-US, and LSIL.
Conclusion:
The available evidence supports the conclusion that reporting xGT results discriminate current and future CIN2+ risks.
Guideline panels must decide whether to separate reporting by individual genotypes or to group genotypes with similar risks into risk tiers. The information in this report is intended to help guideline panels, policymakers, clinicians, and women make informed decisions about the selection of health care services, is intended as a reference, and not as a substitute for clinical judgment. Introduction: HPV-based cervical cancer screening is being implemented in many European countries. Over treating women with a positive high-risk HPV (hr-HPV) test is a main concern. The risk of developing a high-grade (CIN2+) lesion after a positive hr-HPV test needs to be balanced.
Objective: To determine the development of CIN2+ cervical disease in the follow-up (FU) of women with negative cytology and persistently positive high risk HPV (hr-HPV) after co-testing.
Materials and Methods:
From 5.053 women tested with APTIMA ® and ThinPrep ® cytology, 299 cases hr-HPV-positive/cytology negative were genotyped for HPV16 and 18/45 (AHPV-GT).
A baseline biopsy was performed in 195 (65.2%) women. 28 cases with CIN2+ lesions by biopsy were detached from the study. The remaining women were advised to undergo FU at 12 months aligned with EU guidelines. Background : Currently, for the young patients with CIN-2 the trend of the watchful waiting is being formed which compels us to search for the way to objectify the difference of the cytological characteristics between LSIL and HSIL, and the most current and essential at this moment -the difference between CIN-2 and CIN-3, having the distinct prognostic meaning.
Results
Objective: To conduct a morphometric study of the cytological samples of the patients with HPV-associated cervical pathology of different severity and to evaluate abilities of this method in sorting them.
Matherials and methods: Liquid-based cytology (SP BD) was used for the sample preparation. The presence and the titre of HPV of high oncogenic risk were determined using the PCR RT method ("Амплисенс/Amplisense", RF). The following morphometric criteria were evaluated: the nucleus area and the nucleus perimeter, the cytoplasm area and the cytoplasm perimeter, the cell area, the nuclear-cytoplasmic ratio, the nucleus and the cytoplasm optical density. The morphometric studies were performed using the image analysis system Сyto-Vision (West-Medica, RF).
Results:
The test for high risk HPV was positive in all the cases of HSIL and cancer and it was negative in women with NILM. The significant difference was detected for the comparable morphometric criteria between the normal range, the reactive changes and the severe pathology CIN II+ (p < 0.05). Results: The distribution of diagnostic categories was as follows:
Conclusions
Inadequate: 26 (11%); Negative: 168 (71%); Atypical: 8 (3%);
Suspicious: 9 (4%); Positive: 25 (11%). Among them, 28 patients had more than one specimens (up to 5) and 165 patients had clinical follow-up or pathological diagnosis. Malignant diseases were proved in 32 patients (19%) . Secondary malignancies (18/32 = 56%) were more common than primary (14/32 = 44%) and lymphoma (14/ 32 = 44%) was the most common tumor. Cytology results of atypical and up were considered as positive. The sensitivity, specificity, positive predictive value and negative predictive value were 75%, 96%, 83%, and 94%, respectively.
Conclusions: In addition to morphological interpretation, cell block preparation and immunocytochemical stains may aid the cyto-diagnosis. A collaborative team work is the best approach to deal with these specimens and results in high quality cytopathology diagnoses with satisfactory sensitivity and specificity. Results: A total of 372 studies were screened and 51 original articles were eligible for full-text review; finally, 24 studies were chosen for the meta-analysis. Average sample inadequacy was significantly lower in two mainstream LBP methods (ThinPrep and SurePath) than CS. Specificity and sensitivity by sROC were similar or slightly superior for LBP vs CS. Various cytomorphologic changes by each method have been reported. 29 (2.5%) suspicious for malignancy; 97 (8.4%) no diagnostic; 66 (5.7%) other GIST, sarcoma, lymphoma). In suspicious and mucinous lesions KRAS was studied by PCR. Statistical significant differences related to diagnosis and adequacy of samples were obtained comparing solid vs. cystic lesions (p < 0.001). Surgical resection was available in 167 patients and cytological and histological diagnosis was compared with 88% sensitivity 89% specificity, and a PPV of 99%.
Conclusions: Our series is one of the biggest and homogeneous coming from a single institution in Spain. Our results confirm that EUS-guided FNA is a safe and accurate method for diagnosis of pancreatic lesions. Ancillary studies can be performed. Sensitivity, specificity and PPV are extremely high. ROSE is strongly recommended. A learning curve is necessary for both pathologist and ecoendoscopist.
It's mandatory a careful management of the samples. were regarded as suspicious for malignancy; 41 specimens (23%) heralded malignancy, and even though ductal adenocarcinoma/ cholangiocarcinoma accounted for the majority of cases, diagnoses of lymphoma, acinar cell carcinoma and adenosquamous carcinoma were also attained. Finally, 19 cytohistological correlations (11%) were determined; even though the negative and neoplastic (benign/ other) categories revealed to be accurate, the remaining histological diagnoses of malignancy spanned through the atypical, suspicious and positive categories.
O13-3 | Pancreatic Fine-Needle Aspiration
Conclusions: FNAC is a valuable tool to triage pancreatic lesions.
As our low rate of cytohistological correlation discloses, the majority of malignancy-harbouring patients are inoperable; therefore, the role of FNAC becomes pivotal in determining the ensuing clinical efforts and, in our institution, that has translated into a firmly increasing number of annual procedures. ABSTRACTS
